Communicating With Realism and Hope: Incurable Cancer Patients' Views on the Disclosure of Prognosis 5-Hydroxytryptamine-3 receptor antagonists (5-HT 3 antagonists) are effective for preventing acute ...

Nat Clin Pract Oncol. 2005;2(4):196-201. In all three studies, antiemetic treatment was well tolerated with no significant differences in the frequency of adverse events between the three arms. The ...

RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...

LUGANO, Switzerland and WOODCLIFF LAKE, N.J., Oct. 13, 2014 /PRNewswire/ -- Helsinn Group and Eisai Inc. announced today that the Food and Drug Administration (FDA) approved AKYNZEO® for the ...

Heron Therapeutics, Inc. (HRTX) today announced positive, top-line results from its recently completed Phase 3 MAGIC study. MAGIC evaluated the efficacy and safety of the Company's 5-HT3 receptor ...

Palonosetron is as effective as, and in some ways better than, granisetron in preventing the nausea and vomiting that is often experienced after highly emetogenic chemotherapy, conclude the authors of ...

Purpose: The ferret cisplatin emesis model has been used for ~30 years and enabled identification of clinically used anti-emetics. We provide an objective assessment of this model including efficacy ...

The SENRI trial has opened the window to evaluate NK1 antagonists for emesis prevention in patients taking oxaliplatin chemotherapy, antiemetics expert and ESMO spokesperson Fausto Roila said, putting ...

Although brainstem serotonergic (5-HT) systems are involved in the protective responses to hypoxia, abnormalities of 5-HT function are strongly implicated in SIDS, and the neurochemical mechanisms by ...

Ongoing development of new antiemetic drugs in recent years has provided us with a number of effective new agents. These compounds provide an opportunity to further improve the control of CINV in ...